-
Mashup Score: 0Episode 447 - 11 day(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 1November/December - 22 day(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
The November/December issue is now available at: https://t.co/ccjZQYPuQI #RetinalPhysician #retinasurgery #practicemanagement #Stargardt #Clinicaltrials https://t.co/V3x3RQtA8l
-
-
Mashup Score: 1A Successful Annual Meeting - 24 day(s) ago
Retina doctors and their families enjoyed the fourth national meeting of the American Retina Forum, held August 7 to 10 in Carlsbad, California.
Source: www.newretinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Dr. Mitul Mehta discusses highlights of the American Retina Forum's fourth national meeting. Read more: https://t.co/NZZGg5echS #Newretinalphysician #retinalphysician #Americanretinaforum https://t.co/0zUZN8x6Lj
-
-
Mashup Score: 0Clinical Trial Update October 2024 - 25 day(s) ago
Access Retinal Physician’s listing of all active clinical trials in AMD, DME, RVO, and uveitis.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Access Retinal Physician's listing of all active clinical trials in #AMD, #DME, #RVO, and #uveitis here: https://t.co/I7byj3ZvaZ #Retinalphysician #clinicaltrials #clinicaltrialupload https://t.co/GYIUJHRW4a
-
-
Mashup Score: 0Faricimab Effective in Underrepresented DME Patients - 26 day(s) ago
Data from the ELEVATUM trial, presented at AAO, indicates that Hispanic and Black patients with diabetic macular edema responded well to treatment with faricimab.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
ELEVATUM trial data presented at AAO indicates that Hispanic and Black patients with DME responded well to faricimab. Read more: https://t.co/Nmx1cMYUnf #AAO2024 #ElevatumTrial #Faricimab #DiversityInMedicine #HealthEquity https://t.co/qedpcM1Vse
-
-
Mashup Score: 0A Plan for Biosimilar Integration - 26 day(s) ago
Incorporating biosimilars into a retina practice requires thoughtful planning, diligent oversight, and an adaptable mindset.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Derek Burns and Lisa Lasita provide a plan for incorporating biosimilars into a retina practice. Read more: https://t.co/G9Dbm6ndo2 #retinalphysician #biosimilars #antiVEGF #IVItherapy https://t.co/4CgxlnINL6
-
-
Mashup Score: 0Pegcetacoplan an Effective Treatment for Subfoveal GA - 27 day(s) ago
Three-year data from the GALE open-label extension study, presented at AAO, demonstrated an anatomical and visual function benefit of continuous pegcetacoplan treatment for patients with subfoveal geographic atrophy.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Three-year data from the GALE open-label extension study, presented at AAO, demonstrated benefit for patients with subfoveal GA. Read more: https://t.co/7H4HxkHsP0 #AAO #pegcetacoplan #geographicatrophy #GA https://t.co/iHU2svGaBN
-
-
Mashup Score: 1
Evolving approaches to treatment, and advancements in identifying and treating ocular melanomas, have greatly improved patient survival rates and quality of life.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Evolving approaches to treatment have greatly improved survival rates and quality of life for patients with ocular melanoma, Tim Murray, MD, reported at AAO. Read more: https://t.co/rmMeQbwclC #ocularoncology #AAO #chemotherapy #uvealmelanoma #retinoblastoma https://t.co/t0hTjymQvN
-
-
Mashup Score: 0
Data from the SAGA study, presented at AAO, showed patients with geographic atrophy demonstrated a trend toward functional benefit in BCVA at month 24.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Gildeuretinol (ALK-001; Alkeus Pharma) showed a statistically significant visual function benefit in LLVA, according to SAGA trial data presented at AAO 2024. Read more: https://t.co/CP5VAuOa6b #geographicatrophy #AMD #GA https://t.co/6QwxWEIEmE
-
-
Mashup Score: 0Uveitis Corner: Conserved Chemokine Gradients in Uveitis - 29 day(s) ago
A recent study suggests that therapeutically targeting ocular macrophages and the chemokines CCL2 and/or CXCL10 may provide an effective strategy for treating uveitis.
Source: www.retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Lynn Hassman, MD, Joseph Lin, BS, and Kathryn Pepple, MD, discuss their research on conserved chemokine gradients in uveitis. Read more: https://t.co/JDkhHHbJ4Z #retinalphysician #uveitiscorner #uveitis https://t.co/PWNT4BHHRx
-
Dr. Avni Finn and Dr. Sarwar Zahid discuss the current issue with Dr. Sridhar on the Straight from the Cutter’s Mouth podcast. Listen here: https://t.co/0mFbCxtcHn #RetinalPhysician #retinapodcast #practice management #Stargardt #Clinicaltrials #Straightfromthecuttersmouth https://t.co/etugyriI3Q